Eargo

Otolith Labs Expands Leadership Team with the Appointment of Dan Wagner as its Chief Commercial Officer and Raphael Michel to its Board of Directors

Retrieved on: 
Mercredi, février 21, 2024
Biotechnology, Medical Devices, Other Health, Health, Health Technology, Therapy, Boston Scientific, Eargo, Marketing, Hansen Medical, CCO, Olympus Corporation, Stanford University, IPO, Vertigo, Otolith, Johnson & Johnson, Patient, DSM-IV codes, DME, University of California, Berkeley, Pharmaceutical industry

Otolith Labs, a medical technology company developing non-invasive wearable medical devices for the treatment of vestibular disorders, appointed Dan Wagner as Chief Commercial Officer (CCO) and Raphael Michel as an independent Board member.

Key Points: 
  • Otolith Labs, a medical technology company developing non-invasive wearable medical devices for the treatment of vestibular disorders, appointed Dan Wagner as Chief Commercial Officer (CCO) and Raphael Michel as an independent Board member.
  • Otolith Labs’ technology is a head-worn wearable device being investigated for the treatment of vertigo episode symptoms associated with vestibular migraines.
  • “Dan has been working with Otolith in an advisory role for over 5 years, so we are thrilled to have him full-time.
  • “Raphael is one of our earliest industry advisors and has been providing critical counsel to Otolith Labs since 2016.

SHAREHOLDER RIGHTS INVESTIGATION: Halper Sadeh LLC Investigates CSTR, CVLY, EAR, ROVR

Retrieved on: 
Mercredi, janvier 17, 2024
Rover Group, Rover, Nitenpyram, Fraud, Sale, Advertising, Old National Bank, Blackstone Inc., Eargo, Security (finance)

If you are a CapStar shareholder, click here to learn more about your rights and options .

Key Points: 
  • If you are a CapStar shareholder, click here to learn more about your rights and options .
  • If you are a Codorus shareholder, click here to learn more about your rights and options .
  • If you are an Eargo shareholder, click here to learn more about your rights and options .
  • Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct.

STOCKHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger – HA, KRTX, EAR, ICVX

Retrieved on: 
Mardi, janvier 9, 2024
Bristol Myers Squibb, Monteverde, Therapy, EAR, Eargo, Empire, KRTX, Sale, CVR, Alaska Air Group, AstraZeneca, Hawaiian Airlines, Security (finance)

Under the terms of the agreement, HA shareholders will receive $18.00 in cash per share they own.

Key Points: 
  • Under the terms of the agreement, HA shareholders will receive $18.00 in cash per share they own.
  • It is free and there is no cost or obligation to you.
  • Karuna Therapeutics, Inc. (Nasdaq: KRTX ), relating to its proposed sale to Bristol Myers Squibb.
  • Under the terms of the agreement, KRTX shareholders will receive $330.00 in cash per share they own.

SHAREHOLDER RIGHTS INVESTIGATION: Halper Sadeh LLC Investigates HARP, AMAM, AXNX, EAR

Retrieved on: 
Mardi, janvier 9, 2024
Advertising, Harpoon, Eargo, Fraud, Boston Scientific, Johnson & Johnson, Sale, Therapy, Security (finance)

If you are a Harpoon shareholder, click here to learn more about your rights and options .

Key Points: 
  • If you are a Harpoon shareholder, click here to learn more about your rights and options .
  • If you are an Ambrx shareholder, click here to learn more about your rights and options .
  • If you are an Axonics shareholder, click here to learn more about your rights and options .
  • Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct.

ALERT: Juan Monteverde Encourages the Shareholders of CPE, FGH, EAR, BVH to Take Action

Retrieved on: 
Vendredi, janvier 5, 2024
Empire, APA, CPE, Sale, Monteverde, Professional corporation, EAR, FG, FGH, BVH, Eargo, Security (finance)

Under the terms of the agreement, CPE shareholders will receive 1.0425 shares of APA per share they own.

Key Points: 
  • Under the terms of the agreement, CPE shareholders will receive 1.0425 shares of APA per share they own.
  • Under the terms of the agreement, FGH shareholders will receive one share of FG Financial common stock per share they own.
  • Under the terms of the agreement, EAR shareholders will receive $2.55 in cash per share they own.
  • Under the terms of the agreement, BVH shareholders will receive $75.00 in cash per share they own.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SIX, BVH, ROVR, EAR

Retrieved on: 
Lundi, janvier 1, 2024
Cedar Fair, Advertising, Eargo, Blue-green, Fraud, Six Flags, Blackstone Inc., Sale, Rover, Rover Group, Security (finance)

If you are a Six Flags shareholder, click here to learn more about your rights and options .

Key Points: 
  • If you are a Six Flags shareholder, click here to learn more about your rights and options .
  • If you are a Bluegreen shareholder, click here to learn more about your rights and options .
  • Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected] .
  • Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SRC, EAR, BVH, IMGN

Retrieved on: 
Mercredi, décembre 27, 2023
Sale, Eargo, Realty Income, ImmunoGen, Fraud, AbbVie, Advertising, Blue-green, Security (finance)

If you are a Spirit Realty shareholder, click here to learn more about your rights and options .

Key Points: 
  • If you are a Spirit Realty shareholder, click here to learn more about your rights and options .
  • If you are an Eargo shareholder, click here to learn more about your rights and options .
  • Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected] .
  • Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct.

SHAREHOLDER ALERT: Juan Monteverde Encourages the Shareholders of ICVX, EAR, CVLY, IMGN to Take Action

Retrieved on: 
Mercredi, décembre 27, 2023
Empire, CVR, IMGN, AstraZeneca, Sale, Monteverde, EAR, ImmunoGen, AbbVie, Eargo, Security (finance)

Under the terms of the agreement, ICVX shareholders are expected to receive $15.00 in cash and one non-tradeable CVR worth up to $5.00 per share they own.

Key Points: 
  • Under the terms of the agreement, ICVX shareholders are expected to receive $15.00 in cash and one non-tradeable CVR worth up to $5.00 per share they own.
  • Under the terms of the agreement, EAR shareholders will receive $2.55 in cash per share they own.
  • Under the terms of the agreement, CVLY shareholders are expected to own approximately 44% of the outstanding shares of the combined company.
  • Under the terms of the agreement, IMGN shareholders will receive $31.26 in cash per share they own.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IMGN, HA, EAR

Retrieved on: 
Jeudi, décembre 14, 2023
Advertising, Hawaiian Airlines, Eargo, Fraud, Sale, ImmunoGen, AbbVie, Security (finance)

If you are an ImmunoGen shareholder, click here to learn more about your rights and options .

Key Points: 
  • If you are an ImmunoGen shareholder, click here to learn more about your rights and options .
  • If you are a Hawaiian shareholder, click here to learn more about your rights and options .
  • Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected] .
  • Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct.

ALERT: The M&A Class Action Firm Continues Investigating the Merger – EAR, IMGN, CVLY, EVFM

Retrieved on: 
Jeudi, décembre 14, 2023
Empire, IMGN, Sale, Monteverde, EAR, ImmunoGen, AbbVie, OTC, Eargo, Security (finance)

Under the terms of the agreement, EAR shareholders will receive $2.55 in cash per share they own.

Key Points: 
  • Under the terms of the agreement, EAR shareholders will receive $2.55 in cash per share they own.
  • Under the terms of the agreement, IMGN shareholders will receive $31.26 in cash per share they own.
  • Under the terms of the agreement, CVLY shareholders are expected to own approximately 44% of the outstanding shares of the combined company.
  • Evofem Biosciences, Inc. (OTC: EVFM ), relating to its proposed sale to Aditxt, Inc. Click here for more information: https://www.monteverdelaw.com/case/evofem-biosciences-inc .